Second-quarter results beat expectations, and the company projected sales growth.
Related Posts
Temu Suppliers Protest in China, Saying Low-Cost Site Squeezes Them
Suppliers said that many merchants on the shopping platform have shut down factories and incurred debts after it started imposing hefty penalties over what was […]
AstraZeneca Probe in China Adds to Concerns for Foreign Businesses
An investigation involving the drugmaker’s China president is the latest industry crackdown to trigger uncertainty about Beijing’s intentions.
FTC Accuses Drug Middlemen of Inflating Insulin Prices
The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms of inflating the […]